These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29703709)

  • 1. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
    Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
    J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine.
    Hills SL; Van Keulen A; Feser J; Panella A; Letson GW; Staples JE; Marfin AA; Brault AC
    Am J Trop Med Hyg; 2020 Nov; 104(2):576-579. PubMed ID: 33236716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
    Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
    Muniaraj M; Rajamannar V
    Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
    Upreti SR; Lindsey NP; Bohara R; Choudhary GR; Shakya S; Gautam M; Giri JN; Fischer M; Hills SL
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005866. PubMed ID: 28934197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
    Wijesinghe PR; Abeysinghe MRN; Yoksan S; Yao Y; Zhou B; Zhang L; Fleming JA; Marfin AA; Victor JC
    Vaccine; 2016 Nov; 34(48):5923-5928. PubMed ID: 27773472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
    Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
    Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
    Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India.
    Preethi L; Alina MS; Chandran L; Asvin S; Jagadeesan M; Vijayakumar TM; Chitra V; Pandey AK; Reddy MM; Misra BR; Kant R; Bhukya PL; Deshpande GR; Abraham P; Sapkal G; Zaman K
    J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36495206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
    Bouckenooghe A; Bailleux F; Feroldi E
    Hum Vaccin Immunother; 2019; 15(1):72-79. PubMed ID: 30230947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
    Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
    Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
    Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
    Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!
    Vashishtha VM; Ramachandran VG
    Indian Pediatr; 2015 Oct; 52(10):837-9. PubMed ID: 26499003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
    Kim DS; Jang GC; Cha SH; Choi SH; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Bang J; Naimi Z; Bouckenooghe A; Bosch-Castells V; Houillon G
    Pediatr Infect Dis J; 2016 Feb; 35(2):e60-4. PubMed ID: 26535878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.